Fall 2019
Fall classes have begun and our new co-director Pete Groeneveld, MD, MS is off to a running start in his new role in the PennMSHP program. Pete has been involved with the MSHP program since 2005 as an instructor, mentor, and guest lecturer. He brings a unique perspective to the program from his engineering background, his 18 years as a VA primary care physician, and his experience as a cardiovascular health services researcher.

As we welcomed Pete in the early summer, we bid farewell to our 2019 graduates from the summer and fall. A total of 20 students graduated. These 20 graduates have spread around the city and country, taking their research skills and vision for better health care delivery to their new positions in hospital and residency administration, in academic institutions (Penn, Vanderbilt, University of Texas, Harvard), in think tanks, in new fellowships and continued residency training, and in community-based non-profit organizations.
Applications Open for 2020-2022 Cohort of PennMSHP Students
We are currently accepting applicants for our 2020-2022 cohort! As alumni, faculty, and mentors of our program, you are our best resource for getting the word out. Please refer any interested parties to Traci Chupik .
Summer Medical Student Fellows
Pictured above, Robin Wang (second from right) and Parth Shah (far right), completed summer fellowships through MSHP's Medical Student Health Services and Policy Research Summer Research Fellowship . Robin investigated spillover effects of Medicare’s bundled payment programs among commercially insured and Medicare Advantage patients with Amol Navathe, MD, PhD .She was involved in all aspects of the research process, from methodology/study design to data management, statistical analysis/coding, to manuscript writing. As part of her fellowship, she also completed HPR 501, Economics of Health Care Delivery, with Professor Mark Pauly.

Parth worked with Gary Weissman, MD, MSHP to develop a sequence-to-sequence autoencoder, which is a deep unsupervised neural network method used to model large-scale clinical time series data. He worked with a novel dataset of UPHS electronic health records, and developed neural network models to capture dynamic patient states. The two hope that these models can be used in a wide variety of supervised learning tasks for which accurate labeling is difficult (e.g. prediction of sepsis).
Alumni Highlights
Sarah Traxler '15, pictured left, was interviewed on NPR speaking about the downside of Planned Parenthood leaving the federal Title X program, which gives money for family planning to clinics that serve low-income communities. Dr. Traxler is the Chief Medical Officer for Planner Parenthood's North Central States (the Dakotas, Iowa, and Nebraska)

Chethan Bachireddy '18 , asks whether it is more effective to disburse fixed total financial incentives at a constant, increasing, or decreasing rate to encourage physical activity in his latest piece for JAMA Network Open . Dr. Bachireddy was newly appointed Chief Medical Officer of Virginia Medicaid.
Select Student Research
Chris Manz , MSHP second year, published an editorial with Katherine Rendle and Justin Bekelman in BMJ Quality and Safety that explores how vulnerable patients slip through the cracks of cancer care quality metrics. The editorial discusses how cancer quality metrics intended to ensure that patients receive guideline-recommended chemotherapy miss vulnerable patient populations and reflects on the ways that a refined metric could help hospitals and payers improve care for these patients, potentially reducing health disparities .

In a paper for Circulation , Ashwin Nathan , MSHP second year, and team found that direct oral anticoagulant (DOAC) adoption has increased each year since 2012 for patients with venous thromboembolic disease (VTE), exceeding warfarin use in 2016. When assessing for factors associated with use of DOACs, they observed that in a commercially insured population, black race and low household income were independently associated with reduced use of DOACs for incident VTE. These findings suggest the possibility of both racial and socioeconomic inequity in access to this novel pharmacotherapy.

Wishing everyone a lovely and productive fall,